August 18, 2026

Ion Exchange Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-2026 with the Bombay Stock Exchange and the National Stock Exchange of India Limited. The submission, made pursuant to Regulation 34(2)(f) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, outlines the company’s environmental, social, and governance performance.

Strategic Sustainability Targets

The report emphasizes a systems-level approach to conserving resources through water and environmental management solutions. Ion Exchange has established aspirational targets to achieve carbon neutrality by 2030 and net-zero greenhouse gas emissions by 2050. Additionally, the company aims to achieve water positivity across its operations within defined long-term timelines.

These commitments are embedded within the company's strategic roadmap, influencing product innovation and operational efficiency. The report notes that progress against these ESG targets is periodically reviewed by dedicated internal committees with representation from senior management and the Board of Directors.

Governance and Oversight

Mr. Indraneel Dutt, Managing Director & CEO, serves as the highest authority responsible for the implementation and oversight of the Business Responsibility policies. The company has constituted a dedicated core group under his leadership to drive the ESG strategy and monitor performance.

TÜV SÜD South Asia Pvt. Ltd. provided limited assurance for the disclosures in the report. The filings cover standalone operations for Ion Exchange India Ltd., reflecting activities across its engineering, chemical, and consumer product segments.

What the Numbers Show

The BRSR filing indicates a structured integration of sustainability metrics into corporate governance. By linking board-level oversight directly to specific environmental targets such as carbon neutrality and water positivity, the company signals that these non-financial metrics are treated with similar rigor to financial performance indicators. This alignment suggests that capital allocation and operational decisions are increasingly influenced by long-term sustainability outcomes rather than short-term compliance requirements alone.

Ion Exchange reported a mixed financial performance for the first quarter of FY27, balancing robust revenue growth with significant profitability pressures. Consolidated operating income rose 20% year-on-year to ₹701 crore, reflecting double-digit growth across all business segments. However, net profit fell 94% to ₹3 crore, with EBITDA declining 49% to ₹32 crore. The margin compression was primarily attributed to legacy project execution challenges in the treatment solutions segment and higher initial costs at the newly commissioned Roha resin plant.

Segment Reclassification

The company introduced a granular reporting structure for the engineering division, splitting it into three standalone segments: Treatment Solutions, Industrial Products, and Lifecycle Services. This change aims to provide greater transparency into the company's shift from pure project execution toward product-led and recurring revenue models.

What the Numbers Show

A critical divergence exists between top-line momentum and bottom-line realization. While every segment posted double-digit revenue growth—Consumer Products leading at 33% and Lifecycle Services at 28%—the consolidated net profit collapsed. The Specialty Chemicals segment, which contributes over one-third of total revenue, saw its EBIT drop 52% despite a 21% revenue increase. This indicates that the operational leverage from volume growth is currently being entirely offset by the step-up in fixed and variable costs associated with the Roha facility ramp-up and geopolitical input cost fluctuations.

Operational Updates

Management highlighted that the Roha plant is undergoing stabilization, with utilization expected to improve as debottlenecking continues. The company secured a new contract worth approximately $52 million from Hyundai, adding to an order book of ₹2,473 crore as of June 2026. However, the treatment solutions segment remains under pressure from legacy projects, including a government-funded initiative in Uttar Pradesh where fund flows have been constrained. Management indicated that while significant work on these legacy contracts remains, the focus is shifting toward higher-margin advanced solutions and international markets.

Looking ahead, the company plans to leverage its expanded capacity in resins and membranes to capture share in global markets, particularly North America, following the acquisition of Water Quality Association certifications. The leadership emphasized a strategic pivot toward asset-light service models and high-tech emerging solutions, such as lithium extraction and ultrapure water systems, to restore double-digit profitability margins over the medium term.